Because cells expressing FcγRIIb are most prevalent in tumor tissues and tumor draining lymph nodes (TDLNs), we hypothesize that APX005M may not be as active in the circulation due to limited FcR crosslinking. The gene discussed is FCGR2B; the disease is neoplasm.